David Amsellem
Stock Analyst at Piper Sandler
(4.85)
# 388
Out of 4,690 analysts
930
Total ratings
60.5%
Success rate
15.6%
Average return
Main Sectors:
Stocks Rated by David Amsellem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Reiterated: Buy | $44 | $36.44 | +20.75% | 72 | Aug 27, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $310 | $244.54 | +26.77% | 69 | Aug 26, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $165 | $113.88 | +44.89% | 34 | Aug 21, 2026 | |
| AMGN Amgen | Reiterated: Buy | $427 → $457 | $432.42 | +5.68% | 51 | Aug 20, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $298 → $303 | $255.48 | +18.60% | 26 | Aug 20, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $258 | $199.02 | +29.64% | 27 | Aug 18, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $75 | $40.98 | +83.02% | 7 | Aug 17, 2026 | |
| PTHS Pelthos Therapeutics | Reiterated: Buy | $48 | $24.73 | +94.10% | 4 | Aug 14, 2026 | |
| AMPH Amphastar Pharmaceuticals | Reiterated: Hold | $21 → $20 | $22.01 | -9.13% | 41 | Aug 7, 2026 | |
| COLL Collegium Pharmaceutical | Reiterated: Hold | $44 → $43 | $25.32 | +69.83% | 46 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $8.48 | -5.66% | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $47.41 | +37.10% | 42 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 → $210 | $154.06 | +36.31% | 43 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $225 | $218.50 | +2.97% | 31 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $66.58 | +12.65% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 | $43.73 | +50.93% | 70 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $17.54 | -3.08% | 42 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $16.34 | -26.56% | 24 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $59 | $34.87 | +69.20% | 14 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $12.27 | +46.70% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.02 | +59.36% | 7 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $5 → $14 | $13.76 | +1.74% | 18 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $111 | $72.83 | +52.41% | 4 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $46 | $39.21 | +17.32% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $9 | $9.60 | n/a | 19 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $12 | $25.76 | n/a | 39 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4.17 | $8.78 | n/a | 64 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $4.13 | n/a | 9 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $12 | $1.82 | n/a | 12 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $17 | $0.925 | n/a | 29 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $0.0075 | n/a | 7 | May 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $3 | $37.00 | n/a | 5 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $175 | $0.0001 | n/a | 7 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $27.96 | n/a | 1 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $1.20 | n/a | 10 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0001 | n/a | 1 | Nov 11, 2013 |
Teva Pharmaceutical Industries
Aug 27, 2026
Reiterated: Buy
Price Target: $44
Current: $36.44
Upside: +20.75%
Jazz Pharmaceuticals
Aug 26, 2026
Reiterated: Buy
Price Target: $310
Current: $244.54
Upside: +26.77%
Corcept Therapeutics
Aug 21, 2026
Reiterated: Buy
Price Target: $165
Current: $113.88
Upside: +44.89%
Amgen
Aug 20, 2026
Reiterated: Buy
Price Target: $427 → $457
Current: $432.42
Upside: +5.68%
AbbVie
Aug 20, 2026
Reiterated: Buy
Price Target: $298 → $303
Current: $255.48
Upside: +18.60%
Axsome Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $258
Current: $199.02
Upside: +29.64%
Definium Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $75
Current: $40.98
Upside: +83.02%
Pelthos Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $48
Current: $24.73
Upside: +94.10%
Amphastar Pharmaceuticals
Aug 7, 2026
Reiterated: Hold
Price Target: $21 → $20
Current: $22.01
Upside: -9.13%
Collegium Pharmaceutical
Aug 7, 2026
Reiterated: Hold
Price Target: $44 → $43
Current: $25.32
Upside: +69.83%
Aug 7, 2026
Reiterated: Hold
Price Target: $8
Current: $8.48
Upside: -5.66%
Aug 6, 2026
Reiterated: Buy
Price Target: $65
Current: $47.41
Upside: +37.10%
Jul 31, 2026
Reiterated: Buy
Price Target: $207 → $210
Current: $154.06
Upside: +36.31%
Jul 28, 2026
Rated: Buy
Price Target: $225
Current: $218.50
Upside: +2.97%
Jul 28, 2026
Rated: Buy
Price Target: $75
Current: $66.58
Upside: +12.65%
Jul 27, 2026
Reiterated: Buy
Price Target: $66
Current: $43.73
Upside: +50.93%
Jul 20, 2026
Reiterated: Buy
Price Target: $17
Current: $17.54
Upside: -3.08%
Jun 4, 2026
Maintained: Hold
Price Target: $12
Current: $16.34
Upside: -26.56%
May 22, 2026
Reiterated: Buy
Price Target: $54 → $59
Current: $34.87
Upside: +69.20%
May 15, 2026
Reiterated: Buy
Price Target: $18
Current: $12.27
Upside: +46.70%
May 15, 2026
Reiterated: Buy
Price Target: $8
Current: $5.02
Upside: +59.36%
Apr 28, 2026
Upgraded: Hold
Price Target: $5 → $14
Current: $13.76
Upside: +1.74%
Apr 23, 2026
Maintained: Buy
Price Target: $94 → $111
Current: $72.83
Upside: +52.41%
Apr 22, 2026
Reiterated: Buy
Price Target: $48 → $46
Current: $39.21
Upside: +17.32%
Mar 21, 2025
Downgraded: Hold
Price Target: $15 → $9
Current: $9.60
Upside: n/a
Nov 7, 2024
Reiterated: Hold
Price Target: $11 → $12
Current: $25.76
Upside: n/a
Oct 31, 2024
Reiterated: Sell
Price Target: $4.17
Current: $8.78
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $21 → $18
Current: $4.13
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $1 → $12
Current: $1.82
Upside: n/a
Aug 9, 2023
Downgraded: Sell
Price Target: $26 → $17
Current: $0.925
Upside: n/a
May 25, 2022
Maintained: Buy
Price Target: $2
Current: $0.0075
Upside: n/a
Nov 10, 2021
Reiterated: Buy
Price Target: $20 → $3
Current: $37.00
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $6 → $175
Current: $0.0001
Upside: n/a
Jan 23, 2019
Upgraded: Hold
Price Target: n/a
Current: $27.96
Upside: n/a
Oct 12, 2017
Reiterated: Hold
Price Target: $3 → $2
Current: $1.20
Upside: n/a
Nov 11, 2013
Initiated Coverage: Buy
Price Target: $6
Current: $0.0001
Upside: n/a